Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Freeze Thaws: US FDA Allowed To Hire Staff For Cures, User Fee Activity

Executive Summary

White House allowed agency to hire some new employees, but lawmakers remain concerned about federal hiring freeze's effect on FDA.


Related Content

FDA User Fee Hearing Hijacked By US Health Care Reform Arguments
Trump's Budget Outline Threatens User Fee Agreements
FDA Gets Broad Exemptions From Federal Hiring Freeze In HHS Memo
US FDA May Find Relief From Trump's Hiring Freeze
A Burning FDA Hiring Freeze Question: What About User Fee-Supported Staff?
US FDA Getting More Money Up Front Under Cures Bill Revisions
The Evolution Of 21st Century Cures Legislation
Cures Bill Authorizes 'Intercenter Institutes,' But Will US FDA Create Them?
FDA's Breakthrough Workload Will Be Eased By Hiring Reviewers With PDUFA VI Funds
Rare Disease Integration Into FDA Reviews Will Grow Under PDUFA VI





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts